Track the CytoMed Therapeutics Ltd stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €9.7m. The latest transaction was disclosed on 11 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Choo Chee Kong. Every trade is openly available.
6
Insider Decl.
n/a
Thresholds
€635,606
5 ops.
Buy Volume
n/a
n/a
Sell Volume
38Σ signal
Buys €635,606n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,156 of 28,752 companies
27.5
score / 100
Value
7
Quality
49
FCF yld-36%
Earn yld-33%
EV/EBITDA·
ROE-50%
Gross mgn79%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.